The AcDPU is a small highly motivated and focussed group. It is the ethos of the group that each clinician takes primary leadership responsibility for clinical and medical aspects for at least one molecule in development. The successful applicant would be expected to be in position to lead all aspects of a project (i.e. Early Development Leader role) either immediately or within approximately 12 months of appointment. Leadership involves all aspects of the project but specific responsibilities include:
• Development and implementation of the clinical development strategy in collaboration with academic and GSK internal experts.
• Provision of medical and scientific input to individual protocol development including First in Human studies
• Definition and development of the clinical safety monitoring plan
• Provision of the medical monitoring support to clinical studies in progress
The AcDPU contributes to earlier phases of drug discovery through collaboration with the DPAc programme. The DPAc programme operates a similar model of partnership with academics but works in the discovery arena i.e. identification of a candidate molecule directed against a novel target. The role would include the opportunity to participate in due diligence activities for potential DPAc opportunities. For ideas that are adopted the successful applicant would be expected to provide clinical input to development of the medicines vision at the beginning of the development process.
A feature of the AcDPU is that our development programmes are conducted in collaboration with external academic partners. A key responsibility of this role is to provide a consistent and reliable point of contact for our academic collaborators.
Qualifications
In selecting assets for development the AcDPU has been agnostic about the therapeutic area of the proposed indication. The drivers for our collaborations are the combination of excellent science and deep clinical insight of our academic collaborators, partnered with the innovative approach to drug development that the AcDPU can bring. The successful applicant will show an ability to apply their existing knowledge to new and potentially unfamiliar indications and patient populations. The AcDPU has been a vigorous and early adopter of alternative and novel trial designs where these can add real value to drug development. The successful applicant will be someone who can show an innovative and scientifically rigorous approach to trial design and a willingness to explore alternative approaches when these can add value. Basic qualifications:
Medically qualified, with postgraduate medical qualification e.g. MRCP (UK) or equivalent clinical accreditation. In addition, academic higher qualification (eg PhD) highly desirable.
Pass it on for Referral Bonus. Not the right role for you, but know someone we should meet? Share with him to earn $1,000 referral bonus.
Subscribe to us
100% Free.
close